These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4338693)

  • 21. [Ultrastructural modifications induced by several drugs on adrenergic nerve endings and on the adrenal medulla].
    Clementi F
    Experientia; 1965 Mar; 21(3):171-6. PubMed ID: 5890429
    [No Abstract]   [Full Text] [Related]  

  • 22. Nerve function after reserpine and axonal flow of amine storage granules.
    Häggendal J; Dahlström A
    Acta Physiol Scand Suppl; 1970; 357():9-10. PubMed ID: 5507630
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: Effects of sodium, ouabain and DMPP on the neuronal efflux of noradrenaline.
    Löffelholz K
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R59. PubMed ID: 4276605
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversal of sympathetic nerve blockade: a comparison of dopa, dopamine, and norepinephrine with their alpha-methylated analogues.
    Conradi EC; Gaffney TE; Fink DA; Vangrow JS
    J Pharmacol Exp Ther; 1965 Oct; 150(1):26-33. PubMed ID: 5853699
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in the large granular vesicles in sympathetic nerve endings under the influence of several pharmacologic agents].
    Motavkin PA; Chertok VM; Bozhko GG
    Biull Eksp Biol Med; 1977 Jun; 83(6):700-1. PubMed ID: 884298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the administration of epsilon amino caproic acid on catecholamine and serotonin levels in the rat and dog.
    Lippmann W; Wishnick M
    J Pharmacol Exp Ther; 1965 Nov; 150(2):196-202. PubMed ID: 5855877
    [No Abstract]   [Full Text] [Related]  

  • 27. Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.
    Thoenen H; Huerlimann A; Haefely W
    J Pharmacol Exp Ther; 1966 Feb; 151(2):189-95. PubMed ID: 5932597
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antidromic activity induced by acetylcholine in the cardiac sympathetic nerve, and noradrenaline liberation under the influence of guanethidine].
    Häusler G; Thoenen H; Haefely W; Hürlimann A
    Helv Physiol Pharmacol Acta; 1968; 26(3):CR352-4. PubMed ID: 5719362
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence that guanethidine does not block adrenergic nerves by acting as a false transmitter.
    Morgan DH; Oates JA; Shand DG
    Br J Pharmacol; 1970 May; 39(1):186P-187P. PubMed ID: 4315986
    [No Abstract]   [Full Text] [Related]  

  • 30. Subcellular localisation of noradrenaline in sympathetic neurons.
    Smith AD
    Pharmacol Rev; 1972 Sep; 24(3):435-57. PubMed ID: 4561223
    [No Abstract]   [Full Text] [Related]  

  • 31. [Contribution to the mechanism of the central effect of reserpine on the tonic and reflex activity of the sympathetic nervous system].
    Rozonov IuB
    Farmakol Toksikol; 1967; 30(5):530-5. PubMed ID: 5598913
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental study of the pathogenesis of uninhibited neurogenic bladder].
    Derzhavin VM; Vishnevskiĭ EL; Gusev BS
    Urol Nefrol (Mosk); 1977; (4):32-6. PubMed ID: 898423
    [No Abstract]   [Full Text] [Related]  

  • 33. Further evidence for the involvement of microtubules in the intra-axonal movement of noradrenaline storage granules.
    Banks P; Mayor D; Tomlinson DR
    J Physiol; 1971 Dec; 219(3):755-61. PubMed ID: 4110191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of noradrenaline in adrenergic axons of rat sciatic nerves after reserpine treatment.
    Dahlström A; Häggendal J
    J Pharm Pharmacol; 1969 Oct; 21(10):633-8. PubMed ID: 4390603
    [No Abstract]   [Full Text] [Related]  

  • 35. Epinephrine as a tool to investigate the question of recycling of sympathetic storage vesicles in the heart: chemical and morphological studies.
    Wakade AR; Wakade TD; Müller C; Schwab M
    J Pharmacol Exp Ther; 1982 Jun; 221(3):820-7. PubMed ID: 7086690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of L-DOPA on blood pressure and sympathetic nerve activity after decarboxylase inhibition in cats.
    Watanabe AM; Judy WV; Cardon PV
    J Pharmacol Exp Ther; 1974 Jan; 188(1):107-13. PubMed ID: 4809262
    [No Abstract]   [Full Text] [Related]  

  • 37. Chromogranins in sympathetic nerves.
    Banks P; Helle KB
    Philos Trans R Soc Lond B Biol Sci; 1971 Jun; 261(839):305-10. PubMed ID: 4399623
    [No Abstract]   [Full Text] [Related]  

  • 38. [The connection between the central effect of nitroglycerin and the metabolism of monoamines in the brain].
    Kaverina NV; Vysotskaia NB; Rozonov IuB; Shugina TM
    Biull Eksp Biol Med; 1967 Dec; 64(12):51-5. PubMed ID: 4988229
    [No Abstract]   [Full Text] [Related]  

  • 39. From which part of the neuron does the noradrenaline containing large granular vesicles originate?
    Mráz P; Kapeller K
    Folia Morphol (Praha); 1977; 25(2):144-6. PubMed ID: 873389
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mechanisms of sympathetic function inhibition and its importance in the treatment of hypertension].
    Muscholl E
    Internist (Berl); 1966 Aug; 7(8):405-13. PubMed ID: 4863413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.